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Abstract
Fourier-transformed infrared spectroscopy (FTIR) and molecular dynamics (MD) simulation results are presented to support our hypothesis
that the conformation and the oligomeric state of the HIV-1 gp41 fusion domain or fusion peptide (gp41-FP) are determined by the membrane
surface area per lipid (APL), which is affected by the membrane curvature. FTIR of the gp41-FP in the Aerosol-OT (AOT) reversed micellar
system showed that as APL decreases from ∼50 to 35 Å2 by varying the AOT/water ratio, the FP changes from the monomeric α-helical to the
oligomeric β-sheet structure. MD simulations in POPE lipid bilayer systems showed that as the APL decreases by applying a negative surface
tension, helical monomers start to unfold into turn-like structures. Furthermore, an increase in the applied lateral pressure during nonequilibrium
MD simulations favored the formation of β-sheet structure. These results provide better insight into the relationship between the structures of the
gp41-FP and the membrane, which is essential in understanding the membrane fusion process. The implication of the results of this work on what
is the fusogenic structure of the HIV-1 FP is discussed.
© 2007 Elsevier B.V. All rights reserved.Keywords: HIV; gp41 fusion peptide; Membrane fusion; Conformation; Fourier-transformed infrared spectroscopy (FTIR); Molecular dynamics (MD) simulation1. Introduction
Enveloped viruses such as human immunodeficiency virus
(HIV) and influenza virus infect their target cells by a process
involving cell-specific binding to the cell membrane followed by
fusion of the viral enveloped membrane with cellular membranes
[1]. The enveloped viral protein (fusion protein) is responsible for
the actual membrane fusion step, leading to the release of viral
contents into the target cell and subsequent infection. For many
viruses, a small segment of the fusion protein usually located at
the N-terminus is responsible for the early stage in the membrane
fusion process [2]. This domain is usually referred to as the fusion
domain or fusion peptide (FP). In the case of HIV type 1 (HIV-1),
the envelope glycoprotein gp160 contains two non-covalently⁎ Corresponding author. Tel.: +1 573 882 7241; fax: +1 573 882 4195.
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doi:10.1016/j.bbamem.2007.11.014associated subunits, gp120 and gp41 [1]. The subunit gp120
contains sites for viral binding to target cells containing CD4 [3]
and chemokine coreceptors, primarily CCR5 or CXCR4 [4–7],
while the transmembrane subunit, gp41, is responsible for the
membrane fusion process [8]. The viral glycoproteins are
assembled as coiled-coil homotrimers [2,9–18]. The N-terminal
gp41-FP is highly homologous with corresponding domains of
other enveloped viruses [19], and its first 16 residues (AVGI-
GALFLGFLGAAG) are mostly hydrophobic.
Strong evidence coming from mutagenesis studies of intact
enveloped proteins as well as from synthetic FPs implicates the
role of the FP domain in mediating membrane fusion [20–23].
Synthetic peptides mimicking the N-terminal gp41-FP have also
been shown to cause lipid mixing and membrane fusion [24–
30]. Therefore, structural studies have utilized the synthetic FP
solubilized in lipid micelles or reconstituted in lipid bilayers to
gain insight into the structural requirements for viral fusion
activities. Avariety of experimental methods (NMR, FTIR, CD,
ESR) as well as molecular dynamics (MD) simulations has been
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with the membrane. Studies to date have shown that both gp41-
FP and the influenza HA2 FP display considerable structural
plasticity. It can adopt either the monomeric α-helical or the
oligomeric β-sheet conformations. While shorter, 16- or 23-
residues, gp41-FPs have been found to be in bothα-helical or the
oligomericβ-sheet conformations, longer constructs (such as the
70-residue peptide) which include hydrophilic amino acids or
the whole N-heptad repeats showed only a highly fusogenic β-
sheet structure [31,32]. For shorter FPs (16- or 23-residues), a
consensus has been reached that at higher peptide loading, i.e.,
lower [Lipid]/[Peptide] ratio ([L]/[P]), the oligomeric β-sheet is
favored, while at higher [L]/[P], monomeric α-helical form
dominates. However, even at comparable [L]/[P] in different
membrane mimics, a variety of results were obtained. For
example, all experiments of the FP in micelles revealed pre-
dominantly α-helical structure, at [L]/[P] typically from 100 to
50 [33–38]. On the other hand, for the same range of [L]/[P]
values in lipid bilayers, both the α-helical and β-sheet structures
or their mixture were observed due to an increase of percentage
of β-sheet structure at the expense of the α-helical one [39],
suggesting that the curvature of the membrane has an effect on
the oligomeric and conformational state of the FP. In general, the
membrane surface area, or area per lipid (APL), is higher in
micelles than in bilayers because of the positive curvature in the
micellar surface. At the same time, previous investigations have
demonstrated that the conformation and oligomeric state of the
gp41-FP can be altered by changing the APL while, apparently,
keeping the membrane curvature intact. For example, Nieva
et al. observed that, at [L]/[P] of 75 and 100, α to β transition in
the gp41-FP in 1-palmitoyl-2-oleoylphosphatidylglycerol
(POPG) large unilamellar vesicles (LUV) occurred upon the
addition of 5 mM Ca++ ions [31,40]. Addition of cations,
especially divalent cations, usually causes a decrease in the APL
of lipid bilayers or monolayers with negatively charged head-
groups (although Ca++ ions can change the intrinsic membrane
curvature of certain negatively charged lipid systems and the
hydration state of these lipids). For example, Demel et al. [41]
showed that the addition of Ca++ ions causes a decrease of 5–
9 Å2 in 1,2-dipalmoitoy-sn-glycerol-3-phosphoserine (DPPS)
monolayer. Similarly, Castano and Desbat reported that α to β
transition in FP in a DOPC/Cholesterol/DOPE/DOPG (6/5/3/2)
monolayer took place at [L]/[P]=10 upon application of lateral
compression of the monolayer [39]. However, their study was
conducted at a much lower [L]/[P] ratio, and alternative inter-
pretation of the cause for the observation, such as the FP getting
squeezed out of the monolayer by high pressure and aggregate to
β-sheet structure, is conceivable. Combining the results of these
two lines of studies – the effects of curvature change and the
effects of APL change that may not involve changes in curvature
– leads us to believe that a decrease in the APL either by
changing the curvature of the membrane or by other means, e. g.,
by applying lateral compression or addition of cations, results in
a shift from monomeric α-helical to oligomeric β-sheet
structures. Thus we propose that the conformation and the
oligomeric state of the gp41-FP are determined by the APL and
the effect of the curvature of the membrane surface on theconformation of the gp41-FP is mainly manifested through the
induced change in the APL. Although the effects of APL on the
conformation of the FP have been alluded to in the past (e. g.,
Refs. [31,39]), they have not been systematically studied nor
clearly advocated. To test this hypothesis, we have chosen the
reversed micellar system formed by Aerosol-OT (AOT, sodium
dioctyl sulfosuccinate) as the membrane mimicking system.
Although reversedmicelles have seldom been used in the studies
of the interactions of the FP with membrane mimics, there are
compelling rationales for choosing the AOT reversed micelles
for the present purpose. First, the AOT reversed micelles provide
a water/lipid interface with negative curvature, and with APL
ranging from as low as 30 to about 50 Å2 [42], a range
substantially lower than the membrane models used by previous
studies, typically of 60–80 Å2 for planar bilayer surfaces and for
micellar surfaces with positive curvature. The use of the reverse
micelles adds membrane surface with negative curvature as
mimics, which has not been used in the past in the studies of the
conformation and membrane interaction for FPs, and it
drastically extends the range of APL for our study to adequately
test our hypothesis. Second, the reversedmicellar system offers a
system where the membrane curvature, and thus the APL, can be
fine-tuned by varying the water/lipid ratio (Wo= [water]/[AOT])
[42]. Since the APL is a more quantifiable parameter than the
curvature, we will present the results and discussion in terms of
the variation in APL. It should be born in mind, however, that the
changes in APL are the result of changes in the curvature of the
membrane surface.
In this paper we report results from Fourier-transformed
infrared spectroscopy (FTIR) measurements and from all atom
molecular dynamics (MD) simulations, which taken together
validate our hypothesis that the conformation and the oligomeric
state of the HIV-1 gp41-FP are determined by the APL. FTIRwas
used to determine the conformational state of the fusion peptide in
AOT reversed micelles over a range of water/lipid ratio values
corresponding to a variation of the APL from small (∼35 Å2) to
intermediate (∼50 Å2) values. The conformational information
from FTIR spectra is readily available by analyzing the amide-I
band (1600–1700 cm−1) region. Furthermore, the IR time scale is
faster than that of NMR and as a result, different conformational
states, rather than a time-average over these states, can be
determined from the IR spectra. The MD simulations of gp41-FP
dimers in solvated lipid bilayers reported here were designed to
investigate their transition from α-helical to β-sheet conforma-
tions as a result of the decrease of the APL. The main aim of these
simulations was not to corroborate the findings of our FTIR
experiments but rather to directly look at the effects of APL
changes on conformations of the FP and to complement the FTIR
findings by focusing on the APL region (i.e., from 50 to 70 Å2)
that is not accessible in the AOT reversed micelles.
2. Materials and methods
2.1. Fourier-transformed infrared spectroscopy
A liquid IR cell with CaF2 windows and 15 μM path length was used.
Infrared spectra were taken on a Thermal-Nicolet Nexus 670 Spectrometer with
a deuterated triglyceride sulfate (DTGS) detector at room temperature (∼25 °C).
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4000 cm−1. The solvent spectrum was taken under identical conditions and was
subtracted from the spectrum of each sample.
A stock solution of 1 M AOT (Aldrich, 98%) in octane (Mallinkrodt, 99+%)
was prepared. Appropriate amount of D2O (Cambridge Isotope laboratory,
99.9%) was added to a portion of the stock solution to make the AOT/D2O/
octane reversed micelles at various Wo values. The 23-residue N-terminal FP
(AVGIGALFLGFLGAAGSTMGARS-NH2, FP23) was synthesized and pur-
ified by the University of Missouri Peptide Synthesis Core (purityN90%) and
lyophilized to remove trifluoroacetate (TFA) counterions. However, a small
amount of TFA ions remained in the sample. By using 19F NMR and comparing
with a TFA solution of known concentration, it can be determined that there is
less than one TFA ion per peptide. Nevertheless, a peak at 1674 cm−1 arising
from TFA was observed in the FTIR spectra. Fortunately, there is usually no
signal from the FP in this region of the spectrum and thus the TFA signal does
not mask the important signals from the helical and, especially, the β-sheet
structures. A weighted amount of FP23 was then dissolved in the reversed
micellar solution and the resulting sample was allowed to equilibrate for at least
24 h to ensure complete exchange of the amide protons by deuterium. The lipid/
peptide ratio ([L]/[P]) for each sample was kept at 500, corresponding to very
low peptide loading. By keeping a constant [L]/[P] ratio, the amount of FP in
each sample for Wo=5, 7.5 and 10 varied slightly since the amount of AOT
decreases as Wo decreases (by about 8% from Wo=5 to Wo=10). This [L]/[P]
value of 500 was definitely not maintained at Wo=18, as the solubility of the
peptide in the reversed micelles decreases drastically at this high Wo value. By
recovering the undissolved FP23, it was estimated that only about 30±10% of
the FP intended to keep [L]/[P] at 500 was dissolved in the reversed micelles.
Thus, in fact the [L]/[P] for the sample atWo=18 is well over 1000, and because
of the much reduced solubility of FP23 no spectrum was obtained for WoN18.
2.2. Molecular dynamics
To investigate the APL dependence of the conformational state and stability
of the gp41-FP by means of MD simulations we have built three model systems,
referred to as A1, A2 and B, starting from its all atom structure obtained from
FTIR spectroscopy (PDB entry code 1ERF [37]) and employing the molecular
modeling and visualization program VMD [43]. After completing the MD
simulations reported here, two higher resolution NMR structures of HIV-1 gp41
became available in the PDB (entry codes 2ARI [36], and 2PJV [38]). The small
RMSD between the helical region of 1ERF and 2ARI, along with the stability of
the structure 1ERF during our several ns long MD trajectories lead us to believe
that the MD simulation results reported in the present work are robust and
should be reproducible by using the new higher resolution structures. Each
system consisted of a gp41-FP dimer inserted in a fully solvated bilayer ofFig. 1. (a) Side and (b) top views of the α-helical gp41-FP dimer inserted perpendicu
shown in cartoon representation, the phosphorous atoms of the lipid headgroups are sh
solvent water molecules are shown in line representation. Similarly, side and top v
conformations inserted into the POPE lipid bilayer parallel to its surface are shownpalmitoyloleoylphosphatidylethanolamine (POPE) lipid molecules. In A1 and
A2 the dimer was constructed by duplicating the structure of the 23-residue-long
α-helical FP. The N-termini of the monomers were protonated and the axes of
the α-helices (residues 4 to 12) in each dimer were oriented parallel with each
other and separated by 5 Å. By using the NAMD Energy plugin of VMD, the
relative angular orientation of the monomers with respect to their parallel axes
was determined such that it minimized in vacuum the interaction energy
between them. For A1 (A2) the Membrane plugin of VMDwas used to insert the
α-helical dimer perpendicular (parallel) to the surface of a preequilibrated
rectangular patch of POPE membrane bilayer with solvated lipid headgroups. In
both systems the disordered polar C-termini (residues 17 to 23) of the dimers
were kept outside the membrane during the insertion process. Lipid molecules
within 0.6 Å of the proteins were removed. Next, the membrane–peptide
complexes were solvated by adding two 15 Å thick layers of water to each side
of the membrane by using the VMD plugin Solvate. Water molecules trapped in
the hydrophobic region of the membrane were removed. Finally, the VMD
plugin Autoionize was employed to place at energetically favorable positions 4
Cl− ions to restore the electro-neutrality of the systems. The resulting system A1
(A2) shown in Fig. 1a–b (Fig. 1c–d) had a total of 26,608 (35,038) atoms,
containing 4414 (6349) water molecules, 48 (58) lipid molecules in the
membrane leaflet that contained the α-dimer and 54 (65) in other leaflet.
In model system B the gp41-FP dimer was prepared in an elongated
β-conformation as opposed to the α-conformation used in A1 and A2. This
was achieved by stretching in vacuum the N-terminal fusion domain (residues
1 to 16) of each monomer in system A2 from the initial length of ∼23 Å to
47 Å by means of interactive molecular dynamics [44]. In building system B
the insertion of the β-dimer into the POPE membrane and the subsequent
solvation followed the same protocol as for system A2. The final system B
shown in Fig. 1e–f had 34,573 atoms, with 6194 water molecules and 58 (65)
lipid molecules in the membrane leaflet with (without) the β-dimer.
All MD simulations were preformed with the program NAMD-2.5 [45] by
using the CHARMM27 force field parameters for proteins [46,47] and lipids
[48]. Water molecules were modeled as TIP3P [49]. The non-bonded van der
Waals interactions were cut off at 12 Å, with smooth switching function starting
at 10 Å. Long range electrostatic interactions were treated without cut off by
employing the PME method [50]. An integration timestep of 2 fs was employed
in all simulations by using the SHAKE constraint on all hydrogen atoms [51].
Unless otherwise stated, all simulations were carried out in the NpT ensemble
[52] under normal conditions (T=300 K and p=105 Pa). Langevin dynamics,
with a damping coefficient of 5 ps−1, was used to keep the temperature constant.
The hybrid Nose–Hoover Langevin piston method, with the same decay period
and damping time of 100 fs, was employed to maintain a constant pressure. In
order to minimize finite size effects periodic boundary conditions with flexible
cell were used.lar into the upper leaflet of a POPE lipid bilayer (system A1). The peptides are
own in van der Waals representation while the rest of the lipid molecules and the
iews of the gp41-FP dimers in α-helical (system A2) and β-sheet (system B)
in (c), (e) and (d), (f), respectively. (Images rendered with VMD [43].)
Fig. 2. Top panel: Area per lipid (APL) as a function of the water/lipid ratio (Wo).
Lower panels A–D: The amide-I region (1600–1700 cm−1) of the FTIR
spectrum (solid curve) of gp41-FP in the AOT reversed micelles corresponding
to Wo values indicated by arrows in the top panel. The dashed curves represent
the deconvoluted FTIR bands described in the text.
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several stages. First, the systems were subjected to 3×104 minimization steps by
harmonically restraining the Cα atoms of the proteins and the position of the
phosphorous atoms of the lipid headgroups along the normal direction to the
surface of the membrane. Next, the systems were brought to room temperature
by gradual heating during a 0.5 ns period. Finally, after removing all the
restraints, 2 ns (4 ns in case of system A1) long free equilibrations in the NpT
ensemble were carried out for each system. The area of the membrane was kept
constant for A1 and B but allowed to vary for A2. The sizes of the unit cell
corresponding to the built (equilibrated) systems A1, A2 and B were 61×61×
81 Å3 (61×61×69 Å3), 71×61×88 Å3 (71×55×85 Å3), and 56×86×83 Å3
(56×86×69 Å3), respectively.
A set of five MD simulations in the NpT ensemble, referred to as S1, …, S5,
were performed using the equilibrated systems A1, A2 and B. The 30 ns long
simulations S1 and S2 were designed to test the stability of the α-helical
conformation of the gp41-FP monomers in system A1 against helix–coil
transition triggered by the variation of APL. While in S1 the membrane area was
kept fixed, corresponding to APL≈70 Å2, in S2 the membrane area was
increased (or equivalently APL decreased) in time through the application of a
negative surface tension σ=−50 mN/m by setting px=py=pz−σ /ℓz, with
pi =10
5 Pa, (i=x,y,z), the diagonal elements of the pressure tensor [52,53], and
ℓz the length of the unit cell along the z-direction perpendicular on the surface of
the membrane.
The purpose of simulations S3 and S4 of system A2 was to investigate the
APL dependence of the transformation of the α-helical gp41-FP monomers into
turns followed by the formation of β-bridges as precursors of the dimer in the β-
sheet conformation. Since the time scales on which lipid molecules undergo
lateral diffusion in the membrane and monomeric α-helical gp41-FPs unfold
within the membrane are orders of magnitude larger than the longest equilibrium
MD simulations (∼100 ns), we have resorted to nonequilibrium steered
molecular dynamics (SMD) simulations in which properly chosen external
forces are applied to the biomolecular system in order to speed up processes of
interest [54]. In the 5 ns long SMD simulations S3 and S4 the forced unfolding
of the α-helical gp41-FP monomers (system A2) was brought about by pulling
apart the Cα atoms of residues 1 and 16 through a spring (elastic constant
k=1 nN/Å) inserted between them, whose undeformed length was increased
uniformly from 24 Å to 47 Å, which corresponds to the length of a monomer in
the β-structure configuration. In S4 the reduction of the APL was mimicked by
applying an attractive force F0=109 pN/Cα atom (turned on gradually during
the first 1.5 ns of the SMD simulation) between the gp41-FP monomers. No
such confining force was applied during S3.
Finally, the purpose of the 15 ns long equilibrium MD simulation S5,
corresponding to APL=74 Å2, was to investigate the conformational stability of
the β-sheet gp41-FP dimer (system B), and to compare this with the unfolded
structure of A2 at the end of the SMD simulations S3 and S4.3. Results
3.1. Fourier-transformed infrared spectroscopy
The FTIR spectra of the FP23/AOTreversedmicelle sample in
the 1600–1700 cm−1 region atWo values ranging from 5 to 18 are
shown in Fig. 2. Also shown in Fig. 2 is the variation of the APL
(in Å2) as a function of Wo. At high value of Wo=18, cor-
responding to anAPL of∼51Å2 [42], the quality of the spectrum
was quite poor (Fig. 2D), due to the substantially lower solubility
of the FP in the AOT reverse micelles of this composition. A
single peak at 1674 cm−1 was observed (Fig. 2D). As indicated in
the previous section, this peak is due to the residual TFA in the
sample. On the low frequency side of the TFA signal, additional
signal is evident. By deconvolution of the spectral lines, a broad
signal centered around 1650 cm−1 was found. This signal is
commonly assigned to α-helical and random coil structures [55].
Unfortunately it is not easy to distinguish these two structures.Due to the low intensity and the broadness of this peak, it is also
conceivable that it could have arisen from an artifact due to
incomplete subtraction of the background signal. As Wo, and
APL, decrease, another peak at 1627 cm−1 appeared (Fig. 2A–C).
The intensity of the peak at 1627 cm−1 was found to increase
relative to the TFA peak at 1674 cm−1 as Wo decreases. At the
lowest Wo value of 5 in this study, the peak at 1627 cm
−1
completely dominates (Fig. 2A). Strictly speaking, the intensities
of the peak at each wavenumber (1674 and 1627 cm−1) cannot be
compared directly between spectra because of changes in
concentration—the amount of peptide in the sample is smaller
at higher Wo. The amount of FP in the sample cell decreases by
∼8% from Wo=5 to Wo=10, but becomes a particular problem
for the sample at Wo=18, where the FP concentration is
substantially lower because of the drastically reduced solubility.
Thus the intensities of the signal in Fig. 2D are substantially
weaker than the rest of the spectra. Nevertheless, it is
unmistakable that the intensity of the peak at 1627 cm−1 increases
significantly (relative to the TFA peak and to the broad signal
centered around 1650 cm−1) as Wo decreases.
The 1627 cm−1 signal is commonly assigned to the anti-parallel
β-sheet structure [39]. At the low peptide loading ([L]/[P]=500)
that was used in this work, and even at higher peptide loading
(e. g. [L]/[P]∼100) α-helical structure was usually found to
dominate, definitely in micelles [33–36], and even in bilayers
and monolayers (APL of 60 Å2 or higher). We believed that
when the APL has decreased below 50 Å2 (Wob18 in the AOT
system) the lateral compression causes the α-helical monomers
Fig. 3. Time evolution of APL (top panel) and of the lipid bilayer thickness
(bottom panel) during MD simulations S1 (dashed line) and S2 (solid line) of
system A1 described in the text.
Fig. 4. Time evolution of the color coded secondary structure elements of the
two gp41-FP monomers during the 30 ns long equilibrium MD trajectories S1
and S2 of system A1 described in the text. The residue numbers are on the
vertical axis. In each panel the top (bottom) graph refers to the first (second)
monomer. (Figure generated with the Timeline plugin of VMD [43]).
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discussed in the next section), and then the monomers in the
transient turn-structures aggregate and form β-sheets. The
oligomeric β-sheet structure ultimately becomes the dominant
form at the lowest end of the APL range of our study. The
approximate values for the ratios of the intensities of the β-
sheet/(α-helical+ random coil) are 1.6, 1.5 and 0.45 for Wo=5,
7.5 and 10, respectively (Fig. 2), while at Wo=18, no β-sheet
signal was observed. Bear in mind that these numbers are
highly qualitative. Thus the results support our hypothesis that
the APL determines the oligomeric state and the conformation
of the gp41-FP. The monomeric α-helical conformers of the FP
turn increasingly into oligomeric β-sheet structure as APL
decreases. Whether α to β transition was observed in this study
involving the chosen range of low APL is not as clear-cut as we
would like it to be. However, even if the broad signal at
1650 cm−1 does not arise from the α-helical structure but rather
from an artifact, this may simply mean that at this range of low
APL value, α-helical structure no longer exists. It must be
emphasized that as Wo decreases, it is unmistakable that the
signal corresponding to the β-sheet structure becomes more
dominant relative to both the TFA signal and to the putative α-
helical signal. Since the only source of TFA was from the
peptide, the TFA signal serves as a reliable internal standard
that clearly showed the growth of the β-sheet signal asWo (and
the APL) decreases. And thus the β-sheet structure is preferred
at low APL, consistent with our hypothesis.
3.2. Molecular dynamics
Throughout the simulations, due to the strong electrostatic
interaction between their protonated N-termini and the negatively
charged phosphate groups, the monomers remained in close
proximity to the surface of the membrane. In case of system A1,
where the α-helical monomers were inserted perpendicularly into
the upper leaflet of the membrane, the N-termini moved rapidly to
the surface already during the minimization phase of the MD
simulation thus bringing the gp41-FP monomers in a position
similar to the one in system A2.In Fig. 3 the time evolution of the APL and the lipid bilayer
thickness d is shown during the 30 ns long MD simulations S1
and S2. While during S1 both of these quantities remained
constant (i.e., APL≈70 Å2, and d≈34Å), in S2 as a result of the
applied surface tension lead to a gradual decrease (increase) of
the APL (d) to∼50 Å2 (45 Å). According to our hypothesis that
the conformational and oligomeric state of the gp41-FP is
mainly determined by the APL, the dramatic reduction of the
APL during S2 should lead to the destruction of the α-helical
structure of the monomers A1, and their eventual transition into
the more stable β-conformation at APLb50 Å2. To test this the
secondary structure elements of the gp41-FP were calculated
along both S1 and S2MD trajectories by employing the STRIDE
[56] algorithm as implemented in the program VMD [43] with
the results shown in Fig. 4. At the beginning of the simulations
S1 and S2 the α-helical regions of the A1monomers extend only
from residues 4 to 12 and 4 to 9, respectively. Note that the
helical turns up to residue 16 have unwound during the
minimization and equilibration process of A1 when the axes of
the helices have rotated from the insertion direction (perpendi-
cular to the membrane) to an orientation near parallel to the
surface of the membrane. While during both S1 and S2 there are
noticeable dynamic fluctuations in the lengths of the α-helices
(colored red in Fig. 4) the trend in the structural changes of the
monomers is rather different in the two cases. In S1 the α-helices
are quite robust against turn- (gray regions in Fig. 4) and looser
π-helix-structure (orange regions in Fig. 4) formation. Interest-
ingly, in case of the first monomer, during 21 to 23 ns of S1 theα-
helix completely disappears before it reforms again. No such
refolding process has been observed during S2. In fact, during
S2 the transition of the gp41-FP monomers into turn- and π-
helical-structures appears to be gradual and lasting, in agreement
with the hypothesis that decrease in APL does not favor the α-
Fig. 5. Time evolution of the color coded secondary structure elements of the
two gp41-FP monomers during the 5 ns long MD trajectories S3, S4 of system
A2, and S5 of system B described in the text. The residue numbers are on the
vertical axis. In each panel the top (bottom) graph refers to the first (second)
monomer. (Figure generated with the Timeline plugin of VMD [43]).
Fig. 6. Time evolution of the distance between the corresponding centers of mass
of residues 3–4 (top panel), residues 7–8 (middle panel) and residues 12–13
(bottom panel) in the two gp41-FP monomers during the 5 ns SMD simulations
S3 (dashed line) and S4 (solid line) of system A2 described in the text. For
comparison, the time dependence of the corresponding distances in system B
during simulation S5 are also shown (dash-dotted line).
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the S1 and S2 MD trajectories indicate that the unwinding of the
α-helices are triggered by the occasional strong stochastic
pulling exerted by the negative POPE phosphate group on the
protonated N-terminus of the gp41-FP. Because of geometrical
constraints, by decreasing the APL the rewinding of the helix
becomes less favorable compared to its unwinding, thus at the
end leading to the melting of the helical structure.
As already mentioned, the transition of gp41-FP from α- to
β-structure in a lipid membrane occurs on a time scale that is
beyond the reach of conventional MD simulation, even if a large
negative surface tension is applied to mimic the reduction of the
APL. In the nonequilibrium SMD simulations S3 and S4 (see
Materials and methods section) the unwinding of the α-helices
in the gp41-FP monomers (system A2) was accelerated by
applying an elastic stretching force between Cα1 and Cα16. In
addition, to mimic reduction of the APL, in case of S4 the gp41-
FP monomers were pushed one towards the other by applying a
constant force between the corresponding centers of mass of
residues 3–9 and 10–16, respectively. The time evolution of the
secondary structure elements during the 5 ns long SMD simu-
lations S3 and S4 was monitored similarly to S1 and S2, and the
results are shown in Fig. 5. Due to the applied SMD forces in
both S3 and S4 it took only a few ns for the initial α-helices
(red) to melt into turns (gray) followed by the emergence of β-structures (green and blue). It should be noted that a quantitative
analysis of S3 and S4, as well as, their direct comparison with
S1 and S2 is rather difficult because of the large irreversible
perturbation exerted on the system by the SMD forces.
However, a direct comparison between S3 and S4 is meaningful
and can be used to provide further insight into how the decrease
in APL accelerates and, therefore, favors the α- to β-structure
transition in gp41-FP dimers. As shown in Fig. 5, compared
to S3 in S4 the melting of the α-helices and the formation of the
β-bridges and precursors of β-sheets occur faster, the latter
also being more extended. Indeed, in Fig. 5 the locations of the
β-structures in A2 at the end of S4 correspond to the ones in
system B (gp41-FP dimer in initial β-sheet configuration)
during the last 5 ns of simulation S5 described in Materials and
methods section. Furthermore, the stability of the gp41-FP
dimer in β-sheet structure depends crucially on the position and
number of hydrogen bonds between the monomers. In
particular, the separation between the corresponding β-sheet
forming residues 3–4, 7–8 and 12–13 in the two monomers
with parallel orientation must have well defined stable values as
in case of system B. Indeed, as shown in Fig. 6 these three
distances, i.e., d3–4, d7–8 and d12–13, for system B (dash-dotted
lines) do not change noticeably during simulation S5 (only the
last 5 ns are shown). According to Fig. 6, in system A2 the
above mentioned distances converge to the optimal ones of
system B only in case of S4 indicating once again that the
effective reduction of the APL favors the formation of the β-
structure in the gp41-FP dimer. Finally, in Fig. 7 the time
evolution of the number of hydrogen bonds (counted every
10 ps and averaged over time windows of 500 ps) is shown
during simulations S3, S4 and the final 5 ns of S5. While this
number fluctuates around 4 in case of system B in S5, in case of
system A2 increases steadily from zero to a finite value during
S3 and S4. As expected, the final value of the number of
Fig. 7. Time evolution of the average number of hydrogen bonds between the
two gp41-FP monomers during the MD simulations S3 (dashed line), S4 (solid
line) and S5 (dash-dotted line) described in the text. Inset: Location and relative
frequency distribution of the hydrogen bonds between the two gp41-FP
monomers corresponding to the last 1 ns of the S3, S4 and S5 MD trajectories.
951B. Barz et al. / Biochimica et Biophysica Acta 1778 (2008) 945–953hydrogen bonds is clearly larger for S4 than in case of S3. Also,
the relative frequency and location of the hydrogen bonds in A2
for S4, as shown in the inset to Fig. 7, resemble more closely to
those of system B than in case of S3.
4. Discussion and conclusions
Previous structural studies of the structure of the HIV gp41
fusion peptides in membrane environments led to a variety of
structures, resulting in suggestions of conformational plasticity
of the FP [25,27], and its relevancy to the fusogenicity of the
fusion domain. In this study, a major factor affecting the
structure (and oligomeric state) adopted by the HIV gp41-FP,
the surface area of the membrane or APL, has been revealed.
Our hypothesis, that the structure and oligomeric state of the FP
is determined by the APL of the membrane surface, and that the
effects of changes in the curvature of the membrane surface on
the structure of the FP are manifested by the changes in the
APL, has been verified by our FTIR experiments and further
corroborated byMD simulations. By using the seldom exploited
AOT reversed micelles as membrane mimics in our FTIR
studies, we have extended the APL range to a low value region
(35–50 Å2) heretofore unexplored. The extension of the APL
range, from normal micelles to planar bilayers/monolayers to
reversed micelles, enables us to confirm convincingly that a
decrease in the APL, due to changes in curvature or due to other
factors such as the addition of Ca++ ions [31,40] or an applied
lateral pressure [39], leads to the oligomerization of the gp41-
FP and the formation of β-sheet structure, while larger APL,
such as in the case of normal micelles, favors monomeric helical
structure. This effect may also explain the recent observations
from solid-state NMR that FP monomers [57] and cross-linked
trimers [58] adopt predominantly α-helical structure in POPC/
POPG bilayers without cholesterol but β-strands in the presence
of cholesterol. The presence of cholesterol in membrane is
known to increase the lateral packing density (lower APL) and
higher conformational order for the lipid chains [12,59–63].
However, the effects of direct interaction of the FP with cho-lesterol on the structure of the FP cannot be ruled out com-
pletely as the cause of the conformational changes observed
[57,58].
The implication of the results of this work on the fusion
process induced by the HIV fusion peptide is a more com-
plicated issue. First the APL used in this study is substantially
smaller than usually found in lipid bilayers. However, it is
generally believed that negative curvature (and smaller APL) in
cell membranes is developed during the early stage of the fusion
process. In such a situation, small APL comparable to those in
the current study may be achieved.
While some studies have shown that both the α-helical and
β-sheet structures of the FP are fusogenic [58,64,65], results of
other work suggested that specific conformation was respon-
sible for membrane fusion [40,65]. Our findings in the present
work are consistent with the conclusions of several previous
studies that implicated the β-sheet structure as the fusogenic
structure. It has been shown that, in the case of gp41, addition of
Ca++ ions [40] or phosphoethanolamine lipid [66] (see also
discussion later in this section) to large unilamellar vesicle
promotes fusion. In both cases, the APL of the vesicle surface is
reduced (although Haque et al. argued that the main effect of the
addition of Ca++ ions is to cause vesicle aggregation [67]). In
addition, it has been well established that cholesterol promotes
fusion of liposomes [68] and is required in the host membrane
for HIV-1 infection [69]. As discussed earlier, the presence of
cholesterol increases the lateral packing density in membrane
and decreases the APL. Furthermore, the longer FP constructs
which adopt predominantly β-structure were found to be much
more fusogenic than the shorter FPs which may adopt either α-
or β-structures [32,68]. Thus, these observations appear to point
to the conclusion that decreases in APL in the membrane
facilitate fusion, probably by converting the FP into the β-sheet
structure, which is the conformation responsible for fusion
activities, as suggested earlier by Nieva et al. [40]. Such con-
formational “switch” and its relevance to the fusion process
have been proposed for the influenza hemmaglutinin (HA)
fusion peptide by Martin, et al. [70]. The Lentz group also
suggested that the β-structure is the fusogenic structure in
neutral lipids, although they left open the possibility of the
α-helical structure as being responsible for fusion in acidic
lipids [65]. It was proposed by Shai's group that the β-sheet
structure would enable the N-terminal part of the gp41 fusion
domain to penetrate and traverse the membrane [32] triggering
the fusion process. Yet the model proposed by the Lentz group
[65] has the β-structure of the gp41-FP penetrating the bilayer
in a parallel (to the bilayer interface) orientation. On the other
hand, early work from DeGrado's laboratory suggested that the
inserted α-helical form causes vesicle membrane disruption
(fusion) whereas the surface-bound β form induces aggregation
of vesicles [30]. More recent work from Tamm's laboratory that
included fusion studies suggested that the α-helical conforma-
tion is responsible for fusion in both HA and HIV FPs [38,71].
Martin et al. [66] showed that the HIV FP can only cause fusion
in large unilamellar vesicles when phosphatidylethanolamine
(PE) was present, and the orientation (oblique insertion) of the
FP with respect to the membrane surface depends on the
952 B. Barz et al. / Biochimica et Biophysica Acta 1778 (2008) 945–953presence of PE. PE has a much smaller APL than many other
lipids, for example, PC. But yet, the conformation of the gp41-
FP they determined in the presence of PE was α-helical, thus
providing yet another contradiction. A most recent work by
Reichert et al. [72], by introducing a single substitution of a D- or
L-CF3-phenylglycine into the gp41-FP23, contended that both
the well-structured α-helical conformation and β-strand oligo-
meric assembly can be ruled out as the rate-determining state.
Rather, fusion appears to involve conformationally disordered
FPs with pronounced structural plasticity [72]. Thus, the issue of
whether the α-helical or the β-sheet structure is the fusogenic
structure will remain as a much-debated question.
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